OTCMKTS:IZCFF

International Zeolite Competitors

$0.13
0.00 (0.00 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.13
$0.13
50-Day Range
$0.09
$0.13
52-Week Range
$0.02
$0.17
Volume1,500 shs
Average Volume16,616 shs
Market Capitalization$4.80 million
P/E RatioN/A
Dividend YieldN/A
Beta0.92

Competitors

International Zeolite (OTCMKTS:IZCFF) Vs. PRVCF, LNGLY, PDGRY, DBHSY, ISVJY, and CNSWF

Should you be buying IZCFF stock or one of its competitors? Companies in the industry of "private households" are considered alternatives and competitors to International Zeolite, including PreveCeutical Medical (PRVCF), Liquefied Natural Gas (LNGLY), PDG RLTY S A EM/S (PDGRY), Debenhams (DBHSY), INTERSERVE PLC/ADR (ISVJY), and Constellation Software (CNSWF).

PreveCeutical Medical (OTCMKTS:PRVCF) and International Zeolite (OTCMKTS:IZCFF) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability.

Analyst Ratings

This is a summary of current ratings and recommmendations for PreveCeutical Medical and International Zeolite, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PreveCeutical Medical0000N/A
International Zeolite0000N/A

Volatility & Risk

PreveCeutical Medical has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, International Zeolite has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

Earnings and Valuation

This table compares PreveCeutical Medical and International Zeolite's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PreveCeutical MedicalN/AN/A$-2,700,000.00N/AN/A
International Zeolite$460,000.0010.43$-200,000.00N/AN/A

International Zeolite has higher revenue and earnings than PreveCeutical Medical.

Profitability

This table compares PreveCeutical Medical and International Zeolite's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PreveCeutical MedicalN/AN/A-391.05%
International ZeoliteN/A-397.26%-20.03%

Summary

International Zeolite beats PreveCeutical Medical on 3 of the 5 factors compared between the two stocks.

Liquefied Natural Gas (OTCMKTS:LNGLY) and International Zeolite (OTCMKTS:IZCFF) are both small-cap oils/energy companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability.

Volatility & Risk

Liquefied Natural Gas has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, International Zeolite has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

Profitability

This table compares Liquefied Natural Gas and International Zeolite's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Liquefied Natural GasN/AN/AN/A
International ZeoliteN/A-397.26%-20.03%

Earnings and Valuation

This table compares Liquefied Natural Gas and International Zeolite's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liquefied Natural GasN/AN/AN/AN/AN/A
International Zeolite$460,000.0010.43$-200,000.00N/AN/A

Liquefied Natural Gas has higher earnings, but lower revenue than International Zeolite.

Analyst Ratings

This is a summary of current ratings and recommmendations for Liquefied Natural Gas and International Zeolite, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Liquefied Natural Gas0000N/A
International Zeolite0000N/A

PDG RLTY S A EM/S (OTCMKTS:PDGRY) and International Zeolite (OTCMKTS:IZCFF) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation.

Volatility & Risk

PDG RLTY S A EM/S has a beta of 3.43, indicating that its stock price is 243% more volatile than the S&P 500. Comparatively, International Zeolite has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

Profitability

This table compares PDG RLTY S A EM/S and International Zeolite's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PDG RLTY S A EM/SN/AN/AN/A
International ZeoliteN/A-397.26%-20.03%

Earnings & Valuation

This table compares PDG RLTY S A EM/S and International Zeolite's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PDG RLTY S A EM/SN/AN/AN/AN/AN/A
International Zeolite$460,000.0010.43$-200,000.00N/AN/A

PDG RLTY S A EM/S has higher earnings, but lower revenue than International Zeolite.

Analyst Recommendations

This is a summary of recent recommendations for PDG RLTY S A EM/S and International Zeolite, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PDG RLTY S A EM/S0000N/A
International Zeolite0000N/A

Summary

PDG RLTY S A EM/S beats International Zeolite on 3 of the 4 factors compared between the two stocks.

International Zeolite (OTCMKTS:IZCFF) and Debenhams (OTCMKTS:DBHSY) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk.

Earnings and Valuation

This table compares International Zeolite and Debenhams' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
International Zeolite$460,000.0010.43$-200,000.00N/AN/A
Debenhams$3.07 billion0.00$-621,240,000.00($2.02)0.00

International Zeolite has higher earnings, but lower revenue than Debenhams.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for International Zeolite and Debenhams, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
International Zeolite0000N/A
Debenhams0000N/A

Volatility and Risk

International Zeolite has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Debenhams has a beta of -0.62, indicating that its share price is 162% less volatile than the S&P 500.

Profitability

This table compares International Zeolite and Debenhams' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
International ZeoliteN/A-397.26%-20.03%
DebenhamsN/AN/AN/A

INTERSERVE PLC/ADR (OTCMKTS:ISVJY) and International Zeolite (OTCMKTS:IZCFF) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability and risk.

Analyst Recommendations

This is a summary of current ratings and target prices for INTERSERVE PLC/ADR and International Zeolite, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
INTERSERVE PLC/ADR0000N/A
International Zeolite0000N/A

Volatility and Risk

INTERSERVE PLC/ADR has a beta of 4.49, indicating that its share price is 349% more volatile than the S&P 500. Comparatively, International Zeolite has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.

Profitability

This table compares INTERSERVE PLC/ADR and International Zeolite's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
INTERSERVE PLC/ADRN/AN/AN/A
International ZeoliteN/A-397.26%-20.03%

Earnings & Valuation

This table compares INTERSERVE PLC/ADR and International Zeolite's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INTERSERVE PLC/ADR$3.88 billion0.00$-176,460,000.00N/AN/A
International Zeolite$460,000.0010.43$-200,000.00N/AN/A

International Zeolite has lower revenue, but higher earnings than INTERSERVE PLC/ADR.

Summary

INTERSERVE PLC/ADR beats International Zeolite on 4 of the 6 factors compared between the two stocks.

Constellation Software (OTCMKTS:CNSWF) and International Zeolite (OTCMKTS:IZCFF) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability and risk.

Analyst Recommendations

This is a summary of current ratings and target prices for Constellation Software and International Zeolite, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Constellation Software02402.67
International Zeolite0000N/A

Constellation Software currently has a consensus price target of $2,020.00, indicating a potential upside of 36.39%. Given Constellation Software's higher probable upside, analysts clearly believe Constellation Software is more favorable than International Zeolite.

Profitability

This table compares Constellation Software and International Zeolite's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Constellation Software9.91%85.65%18.06%
International ZeoliteN/A-397.26%-20.03%

Earnings & Valuation

This table compares Constellation Software and International Zeolite's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Constellation Software$3.49 billionN/A$333 millionN/AN/A
International Zeolite$460,000.0010.43$-200,000.00N/AN/A

Constellation Software has higher revenue and earnings than International Zeolite.

Summary

Constellation Software beats International Zeolite on 7 of the 7 factors compared between the two stocks.


International Zeolite Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
PreveCeutical Medical logo
PRVCF
PreveCeutical Medical
0.7$0.02flat$11.25 millionN/A0.00Gap Down
Liquefied Natural Gas logo
LNGLY
Liquefied Natural Gas
0.5$0.08flat$10.96 millionN/A0.00Gap Up
PDGRY
PDG RLTY S A EM/S
0.5$2.00flat$8.06 millionN/A0.00High Trading Volume
Debenhams logo
DBHSY
Debenhams
0.8$0.01flat$3.07 million$3.07 billion0.00
INTERSERVE PLC/ADR logo
ISVJY
INTERSERVE PLC/ADR
0.5$0.01flat$299,000.00$3.88 billion0.00High Trading Volume
Gap Down
Constellation Software logo
CNSWF
Constellation Software
1.6$1,481.10flat$0.00$3.49 billion82.70Analyst Report
News Coverage
HTKKY
Hitachi Kokusai Electric
0.5$53.89flat$0.00N/A0.00News Coverage
Gap Down
HOPEWELL HOLDIN/ADR logo
HOWWY
HOPEWELL HOLDIN/ADR
0.6$4.80flat$0.00$253.58 million0.00News Coverage
PXGYF
PAX Global Technology
0.4$1.15flat$0.00N/A0.00Gap Down
Purplebricks Group logo
PRPPF
Purplebricks Group
0.4$1.40flat$0.00$140.72 million0.00
KMLXF
Respiri
0.0$0.12flat$0.00$1.48 million0.00
Victoria Oil & Gas logo
VCOGF
Victoria Oil & Gas
0.4$0.03flat$0.00N/A0.00
This page was last updated on 5/8/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.